June 10, 2008 - The use of ultrasound contrast agents during stress echocardiograms is safe, according to results ...
June 10, 2008 - Wright Medical Group Inc., an orthopedic medical device company, said it has acquired certain assets of ...
June 13, 2008 - The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit ...
Contrast Diversification in CT Imaging Across imaging departments, supply variability and growing demand are creating ...
June 10, 2008 - World-wide inventors and leaders in radio frequency identification (RFID), bar coding, and other ...
Small and large medical imaging equipment suppliers alike are struggling with slowed equipment sales resulting from ...
June 10, 2008 - At the Digestive Disease Week Conference, Cook Medical announced that it has been granted 510(k) clearance from the FDA for use of the Evolution Controlled Release Esophageal Stent System, a stent designed to improve the quality of life for patients with esophageal cancer.
Today’s radiology teams are faced with a wide range of growing complexities such as patient and procedure variabilities ...
June 10, 2008 - The U.S. Department of Health and Human Services (HHS) June 3 released two draft guidance documents for ...
June 10, 2008 – Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current ...
Cook Medical's FDA-cleared Evolution Controlled Release Esophageal Stent System is a stent designed to improve the quality of life for patients with esophageal cancer.
AT A GLANCE Organization: Expert Radiology Management Services, LLC Specialty: Subspecialty teleradiology — neuro and ...
Biomarkers are key indicators for pharmaceutical companies in determining which types of drugs to develop for various ...
Candelis received 510(k) marketing clearance for its ImageGrid Mammography Web Viewer and ImageGrid Radiology Web Viewer ...
Acusphere has submitted a New Drug Application (NDA) to the FDA for approval to market Imagify (Perflubutane Polymer Microspheres for Injectable Suspension), an ultrasound imaging agent for the detection of coronary artery disease, which could prove as accurate as nuclear stress testing.
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
June 9, 2008 - The administration of imprecise dosages, particularly to small children, remains a serious problem faced ...
Toshiba Teli America introduced the T24MSA001-MD medical-grade 24-inch LCD color widescreen monitor with full HD (1,080 ...
ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.
With radiologists in short supply, the need for teleradiology services continues to grow and the market has responded in ...
June 9, 2008 - Siemens unveiled the ACUSON SC2000 volume imaging ultrasound system, which acquires nonstitched, real ...
The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s tentatively approved product is a generic of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.
June 9, 2008 – American TeleCare Inc. (ATI) released Quick Notes as a new feature of its inLife/LifeView Telehealth ...
The FDA recently approved Covidien’s contrast delivery system with radiofrequency identification (RFID) technology ...
June 09, 2008 